Jeff Goater is Director at Surface Oncology, Inc. (SURF). They have made 4 open-market trades across 1 company since 2020, most recently 2023-09-08.
CIK 0001656435
1 open-market purchase totalling $16K since 2020, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SURF | 129,222 | $138K |
Shares reported on the most recent Form 4, priced at the 2022-01-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SURF | SELL | 2021-07-21 | 2022-01-14 | $6.10 | $1.6M | -18.5% | -16.4% | -39.6% |
| SURF | SELL | 2021-06-10 | 2021-06-11 | $7.66 | $3.8M | -1.7% | -6.5% | -17.5% |
| SURF | SELL · 10b5-1 | 2021-02-08 | 2021-02-09 | $12.50 | $31K | -27.0% | -27.7% | -37.9% |
| SURF | SELL · 10b5-1 | 2021-02-01 | 2021-02-03 | $10.69 | $27K | +2.9% | -29.9% | -34.1% |
| SURF | SELL | 2021-01-19 | 2021-01-21 | $13.00 | $65K | -17.2% | -30.6% | -48.1% |
| SURF | BUY | 2020-02-05 | 2020-02-07 | $3.23 | $16K | +15.2% | -24.7% | -22.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.